Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination

Clin Adv Hematol Oncol. 2012 Mar;10(3):204-6.

Authors

Deniz Peker¹, Antonio E Martinez, Michael A Schwartz, Mike Cusnir

Affiliation

¹ Arkadi M. Rywlin Department of Pathology, Mount Sinai Medical Center, Miami Beach, Florida, USA. dpeker@msmc.com

PMID: 22402431

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antibodies, Monoclonal, Murine-Derived / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Castleman Disease / complications
Castleman Disease / drug therapy*
Doxorubicin / administration & dosage
HIV Infections / virology
Herpesviridae Infections / complications
Herpesvirus 8, Human
Humans
Male
Middle Aged
Remission Induction
Rituximab
Treatment Outcome

Substances

Antibodies, Monoclonal, Murine-Derived
Rituximab
Doxorubicin

Supplementary concepts

Multi-centric Castleman's Disease